Key Takeaways
- Volume-led growth, margin squeeze: Revenue rose 18% YoY entirely on volumes while subdued pricing, tariff uncertainty and investment spending compressed EBITDA margin to 12.3% from 13.2% YoY.
- Export engine firing despite tariffs: International business grew 36% YoY as the company diversified into Southeast Asia, North Africa and Turkey, partly offsetting US tariff headwinds on textiles.
- Capacity build-out is the FY27 story: Dahej and Unitop expansions commissioned this quarter, with peak utilization targeted by FY28; management sees ₹3,500 crore revenue potential once assets are fully loaded.
- Working capital stretched, not broken: Net working capital days rose to 102 from 95 on agro-season receivables and one large institutional sale; negative operating cash flow this quarter is expected to reverse by year-end.
- What to watch next quarter: Whether tariff uncertainty lifts enough for US customers to resume order-lifting, the pace of new-capacity ramp-up, and any stabilization in the institutional/B2C loss-making segment.
Demand & Pricing Environment
- Volume engine intact, price under pressure: All 18% YoY growth was volume-led; management held prices this quarter but flagged that customer resistance began in September and the outlook is too uncertain to call.
- Tariff shock is real and spreading: Direct US exports are 12-14% of revenue, but indirect exposure through customers who export fabric and agro-formulations to the US is unquantifiable because end-destinations are not disclosed. US customers are currently not lifting orders.
- Textile chemicals caught in the crossfire: The 50% US tariff on textile exports is hitting home textiles, terry towel and garment manufacturers; margin pressure is expected as suppliers plan to share risk case-by-case.
- Diversification is the hedge: The company spent the last 6-10 months building new geographies in Southeast Asia, North Africa, Turkey and Egypt; these are now paying off as domestic demand softened but exports grew.
- Iran sanctions a non-event: Methanol prices spiked ₹8-₹10 on news of US sanctions on Iranian chemical distributors, but methanol is a very small raw material for Rossari and acetic acid imports from Iran are negligible.
Chari: "Every day, there is uncertainty on what is going to be happening next. This uncertainty is killing."
Capacity Expansion & Capex
- Dahej and Unitop now online: 20,000 MTPA at Dahej and 15,000 MTPA of ethoxylation capacity at Unitop (first phase of a planned 30,000 MTPA) were commissioned this quarter; the Dahej plant was capitalized and will scale over 2-3 years to peak utilization by FY28.
- Second phase in the pipeline: The remaining 30,000 MTPA expansion and other capacity additions are progressing and expected to be commissioned over coming quarters; total planned capex outlay is ₹192 crore, funded through internal accruals and debt.
- FY27 capex stream: ₹97 crore and ₹95 crore of projects announced last quarter will come on stream sometime in FY27 across 5-6 projects in a phased manner.
- Ethoxylation running flat out: Unitop Dahej's 30,000 tons are running 24/7/365, even through Diwali, because Reliance's Dahej plant is not operational, creating an EO shortage.
- Unitop capacity rebased: Capacity dropped from ~86,000 tons to ~60,000 tons because the Patalganga facility was closed down.
- FY26-end capacity: Approximately 385,000 tons.
- Thailand blending unit: A small blending unit in Southeast Asia will come on stream by end of Q3; not a large payout.
- Saudi Arabia exploration: Board approved up to USD 8 million for a wholly owned subsidiary in KSA; feasibility studies and ministry discussions are underway, but commercialization is still some distance away.
- Debt stabilizing: Most large capex cash flows have already happened; internal cash flows are expected to cover remaining spend; management is not averse to further debt but expects the debt figure to stabilize at current levels.
New Products & R&D Pipeline
- 50 products in the pipeline: Over the past 6-9 months, teams developed new products in both EO-based and non-EO-based chemistries guided by green chemistry principles, including esters, emulsifiers, enzyme formulations, biocides and disinfectants, all destined for the new facility.
- Biosurfactants scaling up: Facility ramped from pilot scale (1+ ton) to about 10 tons, targeting 250+ tons per year; research initiated on rhamnolipids alongside existing sophorolipids.
- Specialty chemicals breakthroughs: CAPB and CDEA developed with color issues solved; silicon block polymers ramped up from the Romakk subsidiary; silicon surfactant (super wetter) for agro and textile applications; stabilized ester quats for softeners; full range of spin finish products for staple polyester, POY and FDY polymer.
- NMMO capacity doubled: Production capacity increased from 150 to about 300 tons through process improvements.
- Cold powder technology: Plant for polyethylene glycols using cold powder technology installed and under final commissioning.
- Animal health and nutrition: Short and medium chain fatty acids introduced for gut health and antibiotic reduction in poultry; improved vitamin and mineral premix formulations developed with the plant under water trials, expected in production by end of this month.
Segment & Business Performance
| Segment | Trend | Commentary |
|---|---|---|
| Core B2B | ▬ Steady at lower margin | EBITDA margin fell from 15.8% to 14.8% on product mix and ~₹3.5 crore of additional maintenance at Tristar and Dahej; expected to range 14-16% going forward. |
| Textile Chemicals | ▲ QoQ growth, tariff overhang | 10% QoQ growth but US tariffs creating headwinds for home textiles and garments; margin pressure expected as suppliers share risk. |
| International Business | ▲ Strong | 36% YoY in Q2, 27% in H1, driven by deeper penetration with key customers and new geographies. |
| Institutional & B2C | ▼ Soft, improving | Only 1% YoY growth but losses reduced through efficiency efforts; remains a drag on consolidated margins. |
| Buzil-Rossari | ▬ Muted growth, margin focus | Revenue grew only 1.4% vs 25%+ historically because the company is deliberately restricting low-margin products to improve profitability. |
Margins & Profitability
- Consolidated margin walk: EBITDA margin fell 90 bps YoY to 12.3%, driven by subdued pricing, continued investment in new business initiatives, and a 27% YoY rise in other expenses (freight, travel, ~₹3.5 crore maintenance at Tristar and Dahej, B2C costs).
- Core B2B held steadier: Excluding institutional and B2C, core EBITDA remained around 15%, though down from 15.8% to 14.8% on mix and maintenance.
- One-time expense: Approximately ₹2.5 crore in one-time costs this quarter; not expected to recur.
- Freight cost absorption: The company did not drop export prices but absorbed certain freight expenses onto its own account due to tariff issues; these will persist for at least the next two quarters.
- Gross margin flatlining: Management expects gross margin to remain the same in coming quarters, citing extreme global uncertainty.
- H2 EBITDA guidance: Excluding the consumer/institutional business, EBITDA margin expected at 14-16% for H2, similar to H1 levels.
- FY27 is the margin expansion year: Management signaled that margin expansion largely rests in FY27, when new continuous-process facilities come fully on stream and EO availability improves; FY26 should stay in a similar range.
- Expense levels sticky: Expense levels expected to remain at H1 levels for the rest of the year.
Sablok: "This year I think, at least now it's a little difficult for us to really predict how the year is going to end up, but if we can maintain these kinds of margins for this year I think we would be quite happy."
Working Capital & Cash Flow
- Working capital stretched to 102 days: Up from 95 days in March, driven by stretched receivables from tight business conditions and a major institutional sale with a long payment cycle; inventory kept marginally high for strategic reasons.
- Negative operating cash flow: The working capital stretch pushed cash flow negative in Q2; management expects this to ease over the coming two quarters and return to positive by year-end.
- Seasonal pattern at play: Q2 working capital typically stretches because of the agro season; collections improve once the season tapers off, as observed last year.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Dahej capacity peak utilization | New plant to reach full utilization | By FY28 |
| Second-phase capacity commissioning | Remaining 30,000 MTPA expansion and other additions | Over coming quarters |
| Working capital normalization | Return to positive operating cash flow | By year-end (2 quarters) |
| Thailand blending unit | On stream | End of Q3 FY26 |
| Vitamin/mineral premix plant | Into production | End of this month |
| Core B2B EBITDA margin | 14% – 16% range | H2 FY26 |
| Gross margin | Remain the same as current levels | Coming quarters |
| Expense levels | Remain at H1 levels | Rest of FY26 |
| Debt level | Stabilize at current number | No timeline; stated expectation |
| Margin expansion | Largely rests in FY27 when continuous facility and EO availability improve | FY27 |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Revenue | ₹586.1 crore, +18% YoY |
| EBITDA | ₹71.9 crore, margin of 12.3% vs 13.2% in Q2 last year |
| Core EBITDA margin (excl. institutional and B2C) | ~15%, steady; was 15.8% last year, now 14.8% |
| HPPC division growth | +16% YoY |
| TSC division growth | +21% YoY |
| AHN division growth | +29% YoY |
| Exports growth | +36% YoY in Q2, +27% in H1 |
| Export revenue share | ~28% of overall revenues |
| Institutional and B2C business growth | ~1% YoY, +7% QoQ |
| Textile chemicals growth | +10% QoQ |
| Net working capital days | 102 days, vs 95 days in March |
| Total planned capital outlay | ₹192 crore |
| H1 FY26 capex outflow | ~₹142 crore, with another ₹20–25 crore expected |
| One-time expenses in the quarter | ~₹2.5 crore |
| Additional maintenance expense (Tristar and Dahej) | ~₹3.5 crore |
| Ethoxylation capacity at Unitop Dahej | ~30,000 tons, running at full utilization 24/7 |
| New capacity commissioned at Dahej | 20,000 metric tons per annum |
| New ethoxylation capacity at Unitop | 15,000 metric tons per annum, first phase of planned 30,000 |
| Expected asset turns at full utilization | 3–4x |
| Revenue potential with additional capacity | ~₹3,500 crore (per an analyst's math, management called it a fair assumption) |
| Estimated capacity at end of FY26 | ~385,000 tons |
| Board-approved investment in Saudi Arabia subsidiary | Up to USD 8 million |
| Direct export exposure to US | 12–14% of exports |
| HPPC export-domestic split | ~30% exported, ~70% domestic |